retatrutide phase 2 trial type 2 diabetes weight loss 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No plateau — curve still descending The numbers from Lilly's Phase

GLP1s are just one of the tools that we use to help people on their weight loss journeys

Glapp is loved by thousands of Semaglutide users "This was surprisingly good

The combination was worth every penny of the investment

Fermentation of Fiber Beneficial gut bacteria break down dietary fiber into short-chain fatty acids (SCFAs), such as butyrate and propionate

Los investigadores presentaron los detalles de los ensayos clnicos durante la reunin anual de la Asociacin Americana de la Diabetes, celebrada en New Orleans

Available from: Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jdar E, Leiter LA et al (2016) Semaglutide and cardiovascular outcomes in patients with type 2 diabetes